Home Stock Cardinal Health raises full-year earnings forecast, driven by pharmaceutical segment

Cardinal Health raises full-year earnings forecast, driven by pharmaceutical segment

by
0 comment

Investing.com — Cardinal Health (NYSE:CAH), a major healthcare services and products company, has updated its full-year adjusted earnings per share (EPS) forecast. The company now anticipates its non-GAAP EPS for the fiscal year 2025 to be at the high end of its previously projected range of $7.75 to $7.90. The consensus estimate stands at $7.84.

Shares gained 1% in US pre-market trade.

The revision in the company’s earnings forecast is primarily driven by continued strength within the Pharmaceutical (TADAWUL:2070) and Specialty Solutions segment of the business. The company’s new earnings outlook indicates a positive performance trend in this segment.

In addition to its updated earnings forecast, Cardinal Health announced that it will be presenting at the JPMorgan Annual Healthcare Conference.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You Might Also Like
  • Indonesia stocks lower at close of trade; IDX Composite Index down 0.07%
  • European stock markets retreat as Trump’s comments spark trade war concerns
  • China’s Nio says new Firefly EV to go on sale in Europe in H1 2025
  • Experts question bird strike as cause of deadly South Korean airliner crash

You may also like